Concomitant administration of live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) and measles, mumps, rubella (MMR) vaccine: Randomized study in toddlers in Taiwan
Open Access
- 1 September 2014
- Vol. 32 (41) , 5363-5369
Abstract
No abstract availableKeywords
Funding Information
- Sanofi
- Sanofi
- Sanofi Pasteur
This publication has 11 references indexed in Scilit:
- Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed childrenHuman Vaccines & Immunotherapeutics, 2013
- Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12–18 months: Randomized, controlled phase 3 immunogenicity and safety trialHuman Vaccines & Immunotherapeutics, 2012
- Safety and Immunogenicity of a Single Administration of Live-attenuated Japanese Encephalitis Vaccine in Previously Primed 2- to 5-year-olds and Naive 12- to 24-month-oldsThe Pediatric Infectious Disease Journal, 2010
- Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trialsVaccine, 2010
- A cohort study to assess the new WHO Japanese encephalitis surveillance standardsBulletin of the World Health Organization, 2008
- Current use and development of vaccines for Japanese encephalitisExpert Opinion on Biological Therapy, 2007
- Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2–3 September, 2004Vaccine, 2005
- Two-sided confidence intervals for the single proportion: comparison of seven methodsStatistics in Medicine, 1998
- Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccineThe Lancet, 1996
- Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non‐zero risk difference or non‐unity relative riskStatistics in Medicine, 1990